National HealthCare Corporation filings document operating results, dividend actions, governance matters and capital-structure disclosures for a publicly traded senior health care company. The company’s 8-K reports include earnings releases, quarterly common dividend announcements, director appointments and other material-event disclosures, with NHC common stock registered on the NYSE American.
Proxy materials cover annual meeting matters, shareholder voting, board structure and committee governance. The filing record also describes NHC’s skilled nursing, senior living, behavioral health, home care, hospice, pharmacy, rehabilitation and third-party management activities, along with financial reporting topics such as GAAP and non-GAAP results, marketable equity securities and acquired White Oak operations.
National Healthcare Corp. officer and Senior Vice President of Operations reported a sale of company stock. On 12/17/2025, the insider sold 2,454 shares of common stock at a price of $139.42 per share, leaving 0 shares of common stock beneficially owned in the non-derivative table. The insider continues to hold stock options, including options exercisable for 2,400 shares at $53.94 expiring on 03/08/2028, 8,000 shares at $94.10 expiring on 03/05/2029, and 11,000 shares at $90.62 expiring on 02/24/2030, all listed as directly owned.
National HealthCare Corp. insider Michael Ussery, the company’s President and COO, reported several gifts of common stock on 12/17/2025. The transactions, coded "G" and priced at $0, involved small blocks of shares, after which he directly beneficially owned 160,523 shares of National HealthCare common stock. He also holds stock options giving him the right to purchase 4,500 shares at $53.94 exercisable from 03/08/2024 and expiring on 03/08/2028, 9,000 shares at $94.10 exercisable from 03/05/2025 and expiring on 03/05/2029, and 15,000 shares at $90.62 exercisable from 02/24/2026 and expiring on 02/24/2030, all held directly.
National Healthcare Corp’s CEO and director Stephen Flatt reported two transactions in the company’s common stock dated 12/12/2025. Each transaction used code “G” and involved the disposition of 217 and 145 shares, respectively, at a reported price of $0 per share. After these moves, he beneficially owned 60,621 shares of National Healthcare common stock in direct ownership.
The report also lists stock options held by Flatt. He beneficially owned options to purchase 6,147 shares at an exercise price of $53.94 per share expiring on 03/08/2028, 10,000 shares at $94.10 per share expiring on 03/05/2029, and 18,000 shares at $90.62 per share expiring on 02/28/2030, all shown as directly owned. Together, these details outline his current equity stake and option-based exposure to National Healthcare.
National HealthCare Corp. (NHC) senior executive reports option exercise and share withholding. On 12/01/2025, the Senior VP & CIO exercised an option to purchase 3,734 shares of common stock at an exercise price of $63.96 per share, adding 3,734 acquired shares. On the same date, 2,385 shares were disposed of through share withholding at $137.29 per share to cover the exercise price and tax obligations. After these transactions, the executive beneficially owned 14,520.0547 shares of NHC common stock directly.
The report also shows remaining stock options, including options to purchase 7,467 shares at $53.94 per share exercisable from 03/08/2024 until 03/08/2028, 12,000 shares at $94.10 per share exercisable from 03/05/2025 until 03/05/2029, and 13,500 shares at $90.62 per share exercisable from 02/24/2026 until 02/24/2030.
National Healthcare Corp reported insider equity activity by its Senior Vice President of Patient Services. On 11/25/2025, the executive exercised options to purchase 4,000 shares of common stock at $94.10 per share (code M), increasing directly held stock. To cover the exercise price and tax withholding, the company withheld 3,140 shares at a value of $137.95 per share (code F). After these transactions, the executive directly owned 10,608.5455 shares of National Healthcare common stock.
The filing also shows outstanding stock options, including rights to acquire 3,734 shares at $53.94 per share exercisable until 03/08/2028, 8,000 derivative securities remaining from a grant at $94.10 per share expiring on 03/05/2029, and options for 13,500 shares at $90.62 per share exercisable starting 02/24/2026 and expiring on 02/24/2030. The options exercised and held were granted under the company’s 2020 Omnibus Equity Incentive Plan and are stated as exempt from Section 16(b) short-swing profit rules under Rule 16b-3(d).
National HealthCare Corp (NHC) filed a Form 4 reporting that director Emil E. Hassan sold 7,500 shares of common stock on 11/25/2025 in an open market transaction coded “S.” The shares were sold at a price of $138.5164 per share.
After this sale, Hassan directly owns 65,595 NHC common shares. He also holds several stock option awards, each covering 7,500 shares of common stock, with exercise prices ranging from $55.75 to $96.03 and expiration dates between 05/05/2026 and 05/07/2030.
National HealthCare Corp (NHC) CEO and director Stephen Flatt reported insider transactions on a Form 4. On 11/21/2025, he sold 1,000 shares of common stock at $130.33 per share, and after this trade he beneficially owned 59,130 shares. On 11/25/2025, he exercised 1,853 stock options at $53.94 per share, increasing his beneficial ownership to 60,983 shares.
The filing also lists his remaining stock options. He holds 6,147 options with a $53.94 exercise price expiring on 03/08/2028, 10,000 options with a $94.10 exercise price expiring on 03/05/2029, and 18,000 options with a $90.62 exercise price expiring on 02/28/2030. The exercised options were granted under the 2020 Omnibus Equity Incentive Plan and are described as exempt from Section 16(b) under Rule 16b-3(d).
National Healthcare Corp. (NHC) disclosed an initial beneficial ownership report for director Lisa Piercey. The filing states that, as of the reported event date of 11/06/2025, no securities of National Healthcare Corp. are beneficially owned. This is an administrative ownership disclosure required for insiders under securities regulations.
National HealthCare Corp. (NHC) President & COO Michael Ussery reported Form 4 transactions on 11/11/2025. He exercised 4,500 stock options at $53.94 and another 4,500 at $94.10. To cover the exercise price and withholding taxes, the company withheld 1,705 shares and 3,720 shares at $132.20.
After these transactions, he directly beneficially owned 161,523 shares. Remaining option holdings include 4,500 options at $53.94 expiring 03/08/2028, 9,000 options at $94.10 expiring 03/05/2029, and 15,000 options at $90.62 expiring 02/24/2030.
National Healthcare Corp. (NHC) reported insider activity by its Sr. VP of Operations on a Form 4. On 11/11/2025, the executive exercised 2,400 stock options with a $63.96 exercise price and another 4,800 stock options with a $53.94 exercise price, all granted under the 2020 Omnibus Equity Incentive Plan and exempt from Section 16(b) under Rule 16b-3(d.
To cover the exercise price and related tax withholding, the company withheld 1,655 shares and 3,091 shares, reported with transaction code “F” at a price of $132.20. After these transactions, the executive continued to hold common stock directly and also retained unexercised options, including 8,000 options at a $94.10 exercise price expiring on 03/05/2029 and 11,000 options at a $90.62 exercise price expiring on 02/24/2030.